Kidney cancer came back in the brain after more than 2 years of clear scans
Original title: A 73-Year-Old Man With a Late Isolated Brain Metastasis of Clear Cell Renal Cell Carcinoma Following a Durable Complete Response to Lenvatinib-Pembrolizumab, Resulting in Deferred Cytoreductive Nephrectomy.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is one patient's story that doctors wrote up, not a study that tests a treatment.
The short version
One man's kidney cancer returned in his brain, even though scans of the rest of his body stayed clear.
What was studied. This is a report about one patient, a 73-year-old man. He had clear cell kidney cancer that had spread to his lungs, and doctors describe what happened to him over time.
What they found. He was treated with two drugs, lenvatinib and pembrolizumab. His tumors shrank a lot. Surgeons then removed his kidney. His scans stayed clear of cancer outside the brain for more than 2 years. Then he got a headache. A brain MRI found one new tumor in his brain, with no sign of cancer anywhere else. A focused type of radiation controlled that tumor.
What this means, and what it doesn't
What it could mean: New symptoms still matter, even after a long stretch of good scans. If you get a headache or other new brain symptom, it is worth telling your doctor. A brain MRI can find something that body scans miss.
What it doesn't mean: This is one person's story, not a study. It does not mean this will happen to you. It does not mean these drugs failed or were the wrong choice. It is not a new treatment, and it is not a cure. One case cannot tell us how often this happens or who it happens to.
Source: PubMed, July 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.